A Pilot Study of Interstitial Photodynamic Therapy for Recurrent Squamous Cell Carcinoma of the Oropharynx and Oral Cavity

Trial Profile

A Pilot Study of Interstitial Photodynamic Therapy for Recurrent Squamous Cell Carcinoma of the Oropharynx and Oral Cavity

Withdrawn prior to enrolment
Phase of Trial: Phase I

Latest Information Update: 20 Apr 2015

At a glance

  • Drugs Temoporfin (Primary)
  • Indications Head and neck cancer; Oropharyngeal cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 02 Apr 2015 Status changed from recruiting to withdrawn prior to enrolment as reported by ClinicalTrials.gov record.
    • 21 Aug 2014 Planned End Date changed from 1 Sep 2014 to 1 Sep 2017 as reported by ClinicalTrials.gov record.
    • 01 Dec 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top